Austria vs China: Treatment success rate for patients treated for MDR-TB
Austria
67.0%
in 2022
China
68.0%
in 2022
Austria rank
106th
China rank
104th
Treatment success rate for patients treated for MDR-TB over time
- Austria
- China
How they compare
China currently reports 68.0% against 67.0% in Austria, a difference of 1.0%.
The two have swapped places 4 times across 15 shared years of data; in 2008 it was China ahead.
Austria ranks 106th and China ranks 104th of 163 countries.
Across the 3 decades both report, Austria averaged higher in 1 and China in 2.
Head to head by decade
| Decade | Austria | China | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.0% | 46.0% | 11.0% | China |
| 2010s | 71.8% | 48.4% | 23.4% | Austria |
| 2020s | 44.7% | 61.7% | 17.0% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Austria or China?
- China, at 68.0% against 67.0% in Austria as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Austria and China?
- 1.0%, with China ahead.
- How many years of comparable data are there for Austria and China?
- 15 years are reported by both, from 2008 to 2022.
- How do Austria and China rank globally for treatment success rate for patients treated for mdr-tb?
- Austria ranks 106th and China ranks 104th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.